Comparison of computed tomography and magnetic resonance imaging in the assessment of complex renal cysts by using the Bosniak classification

Yenice, Mustafa Gürkan; Şam, Emre; Arikan, Yusuf; Türkay, Rüştü; Atar, Feyzi Arda; Şahin, Selçuk; İnci, Ercan; Tuğcu, Volkan; Taşçı, Ali İhsan

doi:10.1016/j.acuroe.2019.11.005

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These findings suggest that some renal masses such as, papillary or chromophobe, are not easily identified on standard US, therefore surgeons who choose CEUS for active surveillance of renal masses in their patients must beware of such lesions. A retrospective study performed by Yenice et al in 2020, found that the use of MRI for characterizing cystic renal masses resulted in the upgrading and downgrading of Bosniak classification of the masses and ultimately, affected the surgical management of these patients (20). One study claims that multiphase-MRI is highly sensitive at differentiating the enhancement patterns of ccRCC, pRCC and chRCC, suggesting MRI should be used for the management of ncRCC (21).…”

Section: Imagingmentioning

confidence: 99%

Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma

2021

View full text Add to dashboard Cite

Purpose: To review the current literature regarding variant (non-clear) histology of renal cell carcinoma (RCC) and the clinical management of these renal tumors. Material and Methods: A PubMed database search was performed in May 2020 focusing on variant RCC, its diagnosis and associated syndromes, tumor characteristics, and options for management. Results: A broad range of pathological, clinical and diagnostic characteristics amongst non-ccRCC variants were found to have an impact on the overall management of these tumors. The imaging modalities, frequency of surveillance, and timing for intervention were found to be dependent on the type of genetic alterations, type of histology, and tumor growth rates. The timing and type of surgery as well as the systemic therapy are tailored to the specifi c tumor type and patient. Conclusion:The fi ndings of this review suggest that clinical management should be considered and adjusted for patients with non-ccRCC histological variants based on tumor subtype and genetic alterations.

show abstract

Section: Imagingmentioning

confidence: 99%